Document is current
Any future updates will be listed below
-
Authors
Berlot, Ashley A.
Stark, Allison
Islam, Rakin
Zhang, Chenshu
Rodriguez, Carlos J.
Rikin, Sharon https://orcid.org/0000-0002-2280-9033
-
Funding
Funding for this research was provided by:
Health Resources and Services Administration (National Hypertension Control Initiative)
- License Information
-
More Information
Article History
Received: 5 September 2025
Accepted: 18 February 2026
First Online: 2 March 2026
Declarations
:
: The study protocol was reviewed and approved by the Albert Einstein College of Medicine Institutional Review Board. This was a retrospective study of data collected as part of routine clinical care and informed consent for participation was not required.
: Ashley A. Berlot was supported with grants from the National Institutes of Health/National Center for Advancing Translational Science Einstein‐Montefiore CTSA Grant Numbers UL1 TR002556 and UM1TR004400 and received research support from the Helen Ranney Outstanding Women's Fund. She also owns broad based index funds which may include healthcare, though no direct stock ownership in healthcare companies. Carlos J. Rodriguez reports having been a consultant for Merck, Inc., having received personal research funds from Amgen, Inc., and having research grants from the National Heart, Lung, and Blood Institute of the NIH. Sharon Rikin reports having research grants from AHRQ, PCORI, and HRSA.
